STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more
President Trump is criticized in a Senate report for failing to lower drug prices despite making high-profile deals with manufacturers.
Bad Look
tl;dr
Senate Democrats led by Bernie Sanders released a report alleging that drug prices have soared despite President Trump's price-lowering deals. The article also notes medical experts' criticism of a recent review questioning the efficacy of new Alzheimer’s treatments.
Discussion
What's your take?
Loading comments...